Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up

Identifieur interne : 001B54 ( PascalFrancis/Curation ); précédent : 001B53; suivant : 001B55

REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up

Auteurs : Elena Sinforiani [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Chiara Pasotti [Italie] ; Raffaele Manni [Italie] ; Giuseppe Nappi [Italie]

Source :

RBID : Pascal:08-0417080

Descripteurs français

English descriptors

Abstract

In Parkinson's disease (PD) the presence of REM parasonnias as REM Behaviour Disorder (RBD) or vivid dreams/nightmares, is recognized as largely associated with hallucinations, even if the risk of the development of hallucinations seem not to depend on how long the REM parasomnias had been occurring. The aim of this study was to establish if RBDs occurring earlier than hallucinations in PD are predictive of cognitive impairment development. Three groups of PD patients: i) group 1, without RBD and without hallucinations; ii) group 2, with RBD but without hallucinations; iii) group 3, with RBD and hallucinations have been prospectively investigated at baseline and after two years throughout a clinical and neuropsychological evaluation. After two years, the group 1 continued to present normal neuropsychological tests and did not present either RBDs or hallucinations. In the group 2, the frontal impairment evidenced at baseline was confirmed; the onset of newly hallucinations was reported in a subgroup of 12 patients, who proved to be older, with a more severe executive impairment at baseline and with a more severe motor symptoms progression than those RBD patients who had not manifested hallucinations. The group 3, characterized at baseline by a more severe cognitive impairment presented, after two years, a cognitive worsening and a higher mortality rate. The longitudinal but at preliminary step investigation identified a PD subgroup of patients, in whom a common background disease profile, including the presence of RBD, could represent a "red flag" in developing further cognitive impairment.
pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 23
A06       @2 10
A08 01  1  ENG  @1 REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up
A11 01  1    @1 SINFORIANI (Elena)
A11 02  1    @1 PACCHETTI (Claudio)
A11 03  1    @1 ZANGAGLIA (Roberta)
A11 04  1    @1 PASOTTI (Chiara)
A11 05  1    @1 MANNI (Raffaele)
A11 06  1    @1 NAPPI (Giuseppe)
A14 01      @1 Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology @2 Pavia @3 ITA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut.
A14 02      @1 Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology @2 Pavia @3 ITA @Z 1 aut. @Z 4 aut.
A14 03      @1 Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology @2 Pavia @3 ITA @Z 2 aut. @Z 3 aut.
A14 04      @1 Sleep Medicine Unit, IRCCS C. Mondino Institute of Neurology @2 Pavia @3 ITA @Z 5 aut.
A14 05      @1 Department of Neurology and Otolaryngology, University "La Sapienza", Rome and IRCCS C. Mondino Institute of Neurology @2 Pavia @3 ITA @Z 6 aut.
A20       @1 1441-1445
A21       @1 2008
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000196364640130
A44       @0 0000 @1 © 2008 INIST-CNRS. All rights reserved.
A45       @0 22 ref.
A47 01  1    @0 08-0417080
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 In Parkinson's disease (PD) the presence of REM parasonnias as REM Behaviour Disorder (RBD) or vivid dreams/nightmares, is recognized as largely associated with hallucinations, even if the risk of the development of hallucinations seem not to depend on how long the REM parasomnias had been occurring. The aim of this study was to establish if RBDs occurring earlier than hallucinations in PD are predictive of cognitive impairment development. Three groups of PD patients: i) group 1, without RBD and without hallucinations; ii) group 2, with RBD but without hallucinations; iii) group 3, with RBD and hallucinations have been prospectively investigated at baseline and after two years throughout a clinical and neuropsychological evaluation. After two years, the group 1 continued to present normal neuropsychological tests and did not present either RBDs or hallucinations. In the group 2, the frontal impairment evidenced at baseline was confirmed; the onset of newly hallucinations was reported in a subgroup of 12 patients, who proved to be older, with a more severe executive impairment at baseline and with a more severe motor symptoms progression than those RBD patients who had not manifested hallucinations. The group 3, characterized at baseline by a more severe cognitive impairment presented, after two years, a cognitive worsening and a higher mortality rate. The longitudinal but at preliminary step investigation identified a PD subgroup of patients, in whom a common background disease profile, including the presence of RBD, could represent a "red flag" in developing further cognitive impairment.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Trouble cognitif @5 01
C03 01  X  ENG  @0 Cognitive disorder @5 01
C03 01  X  SPA  @0 Trastorno cognitivo @5 01
C03 02  X  FRE  @0 Hallucination @5 02
C03 02  X  ENG  @0 Hallucination @5 02
C03 02  X  SPA  @0 Alucinación @5 02
C03 03  X  FRE  @0 Maladie de Parkinson @2 NM @5 03
C03 03  X  ENG  @0 Parkinson disease @2 NM @5 03
C03 03  X  SPA  @0 Parkinson enfermedad @2 NM @5 03
C03 04  X  FRE  @0 Pathologie du système nerveux @5 04
C03 04  X  ENG  @0 Nervous system diseases @5 04
C03 04  X  SPA  @0 Sistema nervioso patología @5 04
C03 05  X  FRE  @0 Comportement @5 09
C03 05  X  ENG  @0 Behavior @5 09
C03 05  X  SPA  @0 Conducta @5 09
C07 01  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Syndrome extrapyramidal @5 38
C07 02  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 02  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 03  X  FRE  @0 Maladie dégénérative @5 39
C07 03  X  ENG  @0 Degenerative disease @5 39
C07 03  X  SPA  @0 Enfermedad degenerativa @5 39
C07 04  X  FRE  @0 Pathologie du système nerveux central @5 40
C07 04  X  ENG  @0 Central nervous system disease @5 40
C07 04  X  SPA  @0 Sistema nervosio central patología @5 40
N21       @1 273
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:08-0417080

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up</title>
<author>
<name sortKey="Sinforiani, Elena" sort="Sinforiani, Elena" uniqKey="Sinforiani E" first="Elena" last="Sinforiani">Elena Sinforiani</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Pacchetti, Claudio" sort="Pacchetti, Claudio" uniqKey="Pacchetti C" first="Claudio" last="Pacchetti">Claudio Pacchetti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Zangaglia, Roberta" sort="Zangaglia, Roberta" uniqKey="Zangaglia R" first="Roberta" last="Zangaglia">Roberta Zangaglia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Pasotti, Chiara" sort="Pasotti, Chiara" uniqKey="Pasotti C" first="Chiara" last="Pasotti">Chiara Pasotti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Manni, Raffaele" sort="Manni, Raffaele" uniqKey="Manni R" first="Raffaele" last="Manni">Raffaele Manni</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Sleep Medicine Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Neurology and Otolaryngology, University "La Sapienza", Rome and IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">08-0417080</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0417080 INIST</idno>
<idno type="RBID">Pascal:08-0417080</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001165</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B54</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up</title>
<author>
<name sortKey="Sinforiani, Elena" sort="Sinforiani, Elena" uniqKey="Sinforiani E" first="Elena" last="Sinforiani">Elena Sinforiani</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Pacchetti, Claudio" sort="Pacchetti, Claudio" uniqKey="Pacchetti C" first="Claudio" last="Pacchetti">Claudio Pacchetti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Zangaglia, Roberta" sort="Zangaglia, Roberta" uniqKey="Zangaglia R" first="Roberta" last="Zangaglia">Roberta Zangaglia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Pasotti, Chiara" sort="Pasotti, Chiara" uniqKey="Pasotti C" first="Chiara" last="Pasotti">Chiara Pasotti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Manni, Raffaele" sort="Manni, Raffaele" uniqKey="Manni R" first="Raffaele" last="Manni">Raffaele Manni</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Sleep Medicine Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Neurology and Otolaryngology, University "La Sapienza", Rome and IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Behavior</term>
<term>Cognitive disorder</term>
<term>Hallucination</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Trouble cognitif</term>
<term>Hallucination</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Comportement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In Parkinson's disease (PD) the presence of REM parasonnias as REM Behaviour Disorder (RBD) or vivid dreams/nightmares, is recognized as largely associated with hallucinations, even if the risk of the development of hallucinations seem not to depend on how long the REM parasomnias had been occurring. The aim of this study was to establish if RBDs occurring earlier than hallucinations in PD are predictive of cognitive impairment development. Three groups of PD patients: i) group 1, without RBD and without hallucinations; ii) group 2, with RBD but without hallucinations; iii) group 3, with RBD and hallucinations have been prospectively investigated at baseline and after two years throughout a clinical and neuropsychological evaluation. After two years, the group 1 continued to present normal neuropsychological tests and did not present either RBDs or hallucinations. In the group 2, the frontal impairment evidenced at baseline was confirmed; the onset of newly hallucinations was reported in a subgroup of 12 patients, who proved to be older, with a more severe executive impairment at baseline and with a more severe motor symptoms progression than those RBD patients who had not manifested hallucinations. The group 3, characterized at baseline by a more severe cognitive impairment presented, after two years, a cognitive worsening and a higher mortality rate. The longitudinal but at preliminary step investigation identified a PD subgroup of patients, in whom a common background disease profile, including the presence of RBD, could represent a "red flag" in developing further cognitive impairment.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>23</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>SINFORIANI (Elena)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>PACCHETTI (Claudio)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ZANGAGLIA (Roberta)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>PASOTTI (Chiara)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>MANNI (Raffaele)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>NAPPI (Giuseppe)</s1>
</fA11>
<fA14 i1="01">
<s1>Interdepartmental Research Centre for Parkinson's Disease (CRIMP), IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Laboratory ofNeuropsychology, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Parkinson's Disease and Movement Disorders Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Sleep Medicine Unit, IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Neurology and Otolaryngology, University "La Sapienza", Rome and IRCCS C. Mondino Institute of Neurology</s1>
<s2>Pavia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>1441-1445</s1>
</fA20>
<fA21>
<s1>2008</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000196364640130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>08-0417080</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>In Parkinson's disease (PD) the presence of REM parasonnias as REM Behaviour Disorder (RBD) or vivid dreams/nightmares, is recognized as largely associated with hallucinations, even if the risk of the development of hallucinations seem not to depend on how long the REM parasomnias had been occurring. The aim of this study was to establish if RBDs occurring earlier than hallucinations in PD are predictive of cognitive impairment development. Three groups of PD patients: i) group 1, without RBD and without hallucinations; ii) group 2, with RBD but without hallucinations; iii) group 3, with RBD and hallucinations have been prospectively investigated at baseline and after two years throughout a clinical and neuropsychological evaluation. After two years, the group 1 continued to present normal neuropsychological tests and did not present either RBDs or hallucinations. In the group 2, the frontal impairment evidenced at baseline was confirmed; the onset of newly hallucinations was reported in a subgroup of 12 patients, who proved to be older, with a more severe executive impairment at baseline and with a more severe motor symptoms progression than those RBD patients who had not manifested hallucinations. The group 3, characterized at baseline by a more severe cognitive impairment presented, after two years, a cognitive worsening and a higher mortality rate. The longitudinal but at preliminary step investigation identified a PD subgroup of patients, in whom a common background disease profile, including the presence of RBD, could represent a "red flag" in developing further cognitive impairment.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Trouble cognitif</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Cognitive disorder</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Trastorno cognitivo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Hallucination</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Hallucination</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Alucinación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Comportement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Behavior</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Conducta</s0>
<s5>09</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>273</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B54 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001B54 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:08-0417080
   |texte=   REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024